From: Anti-osteoarthritic effects of ChondroT in a rat model of collagenase-induced osteoarthritis
Groups | WBC(K/μL) | NE(K/μL) | LY(K/μL) | MO(K/μL) | EO(K/μL) |
---|---|---|---|---|---|
Intact | 4.10 ± 0.84ab | 0.56 ± 0.06a | 3.38 ± 0.80abc | 0.14 ± 0.03ab | 0.02 ± 0.01a |
Control | 5.47 ± 0.57a | 0.68 ± 0.11a | 4.60 ± 0.48a | 0.18 ± 0.02ab | 0.01 ± 0.00a |
Indomethacin | 4.49 ± 0.40c | 0.61 ± 0.06a | 3.68 ± 0.34abc | 0.19 ± 0.03ab | 0.01 ± 0.00a |
Joins tab | 4.59 ± 0.39ab | 0.66 ± 0.17a | 3.67 ± 0.24abc | 0.18 ± 0.02ab | 0.03 ± 0.03a |
ChondroT50 | 5.48 ± 0.76a | 0.75 ± 0.15a | 4.51 ± 0.62ab | 0.20 ± 0.02a | 0.02 ± 0.01a |
ChondroT100 | 3.79 ± 0.17b | 0.45 ± 0.04a | 3.21 ± 0.18bc | 0.12 ± 0.03b | 0.01 ± 0.00a |
ChondroT200 | 3.70 ± 0.34b | 0.53 ± 0.03a | 3.04 ± 0.37c | 0.13 ± 0.02b | 0.01 ± 0.00a |
F Value | 1.81 | 0.95 | 1.65 | 1.79 | 0.79 |
P Value | 0.1342 | 0.4752 | 0.1706 | 0.1368 | 0.5878 |